BRIEF published on 10/02/2024 at 07:05, 2 years ago Cureus GmbH Marks Four Years with Continued Expansion Expansion Property Development Cureus GmbH Care Homes PECURIA
BRIEF published on 10/02/2024 at 07:05, 2 years ago Cureus GmbH fête ses quatre ans avec une expansion continue Expansion Développement Immobilier Cureus GmbH Maisons De Retraite PECURIE
PRESS RELEASE published on 10/02/2024 at 07:00, 2 years ago Cureus continues to expand and looks back on four successful years of existence to date Cureus expands with new care home projects, sales via PECURIA, and strong growth. IZ Research ranks Cureus as top development firm in Germany. Carestone sells locations individually Expansion Development Cureus PECURIA Care Home
BRIEF published on 07/08/2024 at 07:05, 2 years 3 months ago Cureus Grows and Expands Its Value Chain Real Estate Sustainability Property Development Care Homes
BRIEF published on 07/08/2024 at 07:05, 2 years 3 months ago Cureus se développe et étend sa chaîne de valeur Immobilier Durabilité Développement De La Propriété Les Foyers De Soins
PRESS RELEASE published on 07/08/2024 at 07:00, 2 years 3 months ago Cureus grows and expands its value chain Cureus expands its value chain by starting construction of 248 care units in Q2/24, completing 272 care units, and acquiring a stake in PECURIA. Sustainability report 2023 published Construction Sustainability Report Cureus Value Chain Expansion PECURIA
BRIEF published on 04/09/2024 at 07:05, 2 years 6 months ago Cureus GmbH Reports Strong Start in 2024 with Significant Real Estate Developments Real Estate Sustainability Company Growth Care Home Development Award Recognition
BRIEF published on 04/09/2024 at 07:05, 2 years 6 months ago Cureus GmbH annonce un bon départ en 2024 avec d'importants développements immobiliers Immobilier Durabilité Croissance De L'entreprise Développement Des Maisons De Retraite Reconnaissance Des Récompenses
PRESS RELEASE published on 04/09/2024 at 07:00, 2 years 6 months ago Cureus sees successful start to 2024 Cureus GmbH, a leading property developer specializing in care home portfolio, reports successful Q1 2024 with completed and ongoing projects. Recognized for sustainability and employer quality Sustainability Property Developer Q1 2024 Cureus GmbH Care Home Portfolio
PRESS RELEASE published on 10/09/2023 at 07:00, 3 years ago Cureus in Q3 2023: eight projects with 671 units completed, three properties sold, land acquisition continues
Published on 10/23/2026 at 16:00, 37 minutes ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/23/2026 at 13:23, 3 hours 14 minutes ago Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 3 hours 37 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 13:00, 3 hours 37 minutes ago First Canadian Graphite Inc. annonce un financement accréditif
Published on 10/23/2026 at 02:20, 14 hours 17 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/23/2026 at 16:25, 12 minutes ago Lassa introduces new winter tyre Wintus 3 for light commercial vehicles
Published on 10/23/2026 at 16:10, 27 minutes ago EQS-Adhoc: SGL Carbon sells its former Carbon Fiber facility in Moses Lake (USA)
Published on 10/23/2026 at 15:40, 57 minutes ago Shanghai, Hamburg seek closer ties as friendship turns 40
Published on 10/23/2026 at 07:00, 9 hours 37 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 22 hours 37 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 22 hours 37 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 22 hours 37 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
